Park Ha Biological Technology Co., Ltd./$PHH
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About Park Ha Biological Technology Co., Ltd.
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
Ticker
$PHH
Sector
Primary listing
Industry
Specialty Retail
Headquarters
Employees
17
ISIN
KYG6925R1020
Website
PHH Metrics
BasicAdvanced
$829M
1641.94
$0.02
-
-
Price and volume
Market cap
$829M
52-week high
$31.61
52-week low
$5.15
Average daily volume
468K
Financial strength
Current ratio
1.866
Quick ratio
0.598
Long term debt to equity
3.502
Total debt to equity
4.669
Profitability
EBITDA (TTM)
0.816
Gross margin (TTM)
91.80%
Net profit margin (TTM)
20.09%
Operating margin (TTM)
33.32%
Effective tax rate (TTM)
39.68%
Revenue per employee (TTM)
$140,000
Management effectiveness
Return on assets (TTM)
18.55%
Return on equity (TTM)
38.00%
Valuation
Price to earnings (TTM)
1,641.939
Price to revenue (TTM)
329.891
Price to book
521.72
Price to tangible book (TTM)
524.38
Price to free cash flow (TTM)
898.103
Free cash flow yield (TTM)
0.11%
Free cash flow per share (TTM)
3.50%
Growth
Revenue change (TTM)
-3.14%
Earnings per share change (TTM)
-43.83%
3-year revenue growth (CAGR)
36.77%
3-year earnings per share growth (CAGR)
-1.45%
Bulls say / Bears say
Park Ha Biological Technology Co., Ltd. successfully completed its initial public offering (IPO) on December 30, 2024, raising $4.8 million, which is earmarked for expanding directly-owned stores, acquiring product patents, and securing ingredient suppliers, positioning the company for growth. (globenewswire.com)
The company's gross profit margin improved to 91.80% in fiscal year 2024, up from 87.35% in the previous year, indicating enhanced operational efficiency. (stockanalysis.com)
Despite a slight decrease in revenue, Park Ha Biological Technology Co., Ltd. maintained a net income of $478,561 for the fiscal year ended October 31, 2024, demonstrating resilience in its financial performance. (marketscreener.com)
The company's revenue declined by 3.14% in fiscal year 2024 compared to the previous year, raising concerns about its ability to sustain growth. (stockanalysis.com)
Net income decreased by 43.83% in fiscal year 2024, from $852,042 to $478,561, indicating potential challenges in profitability. (marketscreener.com)
The company's cash reserves decreased to $547,498 as of October 31, 2024, down from $1,033,634 the previous year, which may impact its ability to fund operations and growth initiatives. (sec.gov)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Park Ha Biological Technology Co., Ltd. stock?
Park Ha Biological Technology Co., Ltd. (PHH) has a market cap of $829M as of June 25, 2025.
What is the P/E ratio for Park Ha Biological Technology Co., Ltd. stock?
The price to earnings (P/E) ratio for Park Ha Biological Technology Co., Ltd. (PHH) stock is 1641.94 as of June 25, 2025.
Does Park Ha Biological Technology Co., Ltd. stock pay dividends?
No, Park Ha Biological Technology Co., Ltd. (PHH) stock does not pay dividends to its shareholders as of June 25, 2025.
When is the next Park Ha Biological Technology Co., Ltd. dividend payment date?
Park Ha Biological Technology Co., Ltd. (PHH) stock does not pay dividends to its shareholders.
What is the beta indicator for Park Ha Biological Technology Co., Ltd.?
Park Ha Biological Technology Co., Ltd. (PHH) does not currently have a Beta indicator.